Reporting of drug reaction with eosinophilia and systemic symptoms from 2002 to 2019 in the US Food and Drug Administration Adverse Event Reporting System-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Reporting of drug reaction with eosinophilia and systemic symptoms from 2002 to 2019 in the US Food and Drug Administration Adverse Event Reporting System

Published:2021-08 Issue:8 Volume:9 Page:3208-3211.e1
ISSN:2213-2198
Container-title:The Journal of Allergy and Clinical Immunology: In Practice
language:en
Short-container-title:The Journal of Allergy and Clinical Immunology: In Practice

Author:

Bluestein Sara Beth,Yu Roger,Stone Cosby,Phillips Elizabeth J.

Funder

National Institutes of Health

Agency for Healthcare Research and Quality

National Health and Medical Research Council

Publisher

Elsevier BV

Subject

Immunology and Allergy

Reference8 articles.

1. Clinical, viral and genetic characteristics of drug reaction with eosinophilia and systemic symptoms (DRESS) in Shanghai, China;Wu;Acta Derm Venereol,2018

2. Drug reaction with eosinophilia and systemic symptoms (DRESS): An interplay among drugs, viruses, and immune system;Cho;Int J Mol Sci,2017

3. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (drug rash with eosinophilia and systemic symptoms: DRESS);Bocquet;Semin Cutan Med Surg,1996

4. Controversies in drug allergy: testing for delayed reactions;Phillips;J Allergy Clin Immunol,2019

5. Emerging causes of drug-induced anaphylaxis: a review of anaphylaxis-associated reports in the FDA Adverse Event Reporting System (FAERS);Yu;J Allergy Clin Immunol Pract,2021

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of novel signal of proton pump inhibitor-associated drug reaction with eosinophilia and systemic symptoms: a disproportionality analysis;International Journal of Clinical Pharmacy;2024-07-23

2. How to Define and Manage Low-Risk Drug Allergy Labels;The Journal of Allergy and Clinical Immunology: In Practice;2024-05

3. Drugs associated with serum sickness and serum sickness–like reactions: A review of FDA Adverse Event Reporting System (FAERS) data;The Journal of Allergy and Clinical Immunology: In Practice;2024-05

4. Severe cutaneous adverse reactions;Nature Reviews Disease Primers;2024-04-25

5. Clinical features of drug reaction with eosinophilia and systemic symptoms: A retrospective study in a reference centre of dermatology in Madagascar;JEADV Clinical Practice;2024-04-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3